Roche's Gazyva Gets FDA Approval for Lupus Nephritis
WSJยท2025-10-20 06:40
Core Insights - The FDA has approved Gazyva for treating adults with a specific form of lupus that affects the kidneys [1] Group 1 - Gazyva is now authorized for use in patients undergoing standard therapy for lupus nephritis [1]